You are on the TAC legacy website. Please visit our new website:


warning: Creating default object from empty value in /usr/www/users/tacaor/public_site/community/modules/taxonomy/ on line 34.


Printer-friendly version

Talk About Antiretrovirals

Talk About Antiretrovirals

Pamphlet on antiretrovirals

Publication Year: 

Letter from Head of the Southern African HIV Clinicians Society to Sowetan Newspaper

On Wednesday, Sowetan newspaper ran a disturbing story about a man on antiretrovirals who had a particularly bad case of lipodystrophy and grew breasts. This story highlights the need for doctors and nurses to monitor antiretroviral side-effects closely and to take patients concerns about their side-effects seriously. It also shows how important it is for patients to inform their health providers as soon as they experience possible side-effects. 

TAC letter to President Mbeki about Virodene

TAC Electronic Newsletter


  • Tenofovir Campaign details and memo

TAC Electronic Newsletter


  • Campaign for tenofovir to be registered

Antiretrovirals Give Life


Antiretrovirals Give Life

1 December 2005

On World AIDS Day, two reports have been released demonstrating the success of antiretroviral treatment in developing countries, one from South Africa and the other from Haiti.


Antiretrovirals Give Life

The Faculty of Health Sciences of Wits University would like to take the occasion of World AIDS Day 2005 to publicly share its positive experiences with the use of anti-retroviral therapy (ART) for HIV/AIDS. "This is important in the light of ongoing public confusion and fear surrounding ART, which we believe may prevent people from making use of life saving medication that is increasingly available in the Gauteng province," says Prof. Max Price, Dean of the Faculty of Health Sciences.

Faculty doctors working in public hospitals have been closely associated with the Gauteng Provincial ART programme since its inception in April 2004 and are collectively following up more than 10,000 people on ART. "The results are dramatic and unequivocal, says Dr Francois Venter, an HIV clinician who works at the Johannesburg Hospital and

Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti

New England Journal of Medicine;Volume 353:2325-2334;December 1, 2005; Number 22


Patrice Severe, M.D., Paul Leger, M.D., Macarthur Charles, M.D., Ph.D., Francine Noel, M.D., Gerry Bonhomme, M.D., Gyrlande Bois, M.D., Erik George, M.D., Stefan Kenel-Pierre, B.S., Peter F. Wright, M.D., Roy Gulick, M.D., Warren D. Johnson, Jr., M.D., Jean William Pape, M.D., and Daniel W. Fitzgerald, M.D.

Background: The one-year survival rate of adults and children with the acquired immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 percent in Haiti. Antiretroviral therapy has recently become available in Haiti and in other developing countries. Data on the efficacy of antiretroviral therapy in developing countries are limited. High rates of coinfection with tropical diseases and tuberculosis, along with malnutrition and limited laboratory monitoring of therapy, may decrease the efficacy of antiretroviral therapy in these countries.

Syndicate content